Skip to main content

Anti-Aging Research: Science, not Hype

Last updated December 2022
Q: "How is aging a disease?"

A: "It's a dynamic system that veers away from its homeostasis (normal equilibrium point): hence a form of slow-progressing illness. Labeling it as 'natural' is a surrender to our traditional state of ignorance and powerlessness, which fortunately is beginning to be changed!"
The above is my standard answer to an oft-asked question.

The science of aging is by all evidence very misunderstood by the general public.  Hype, misinformation and unquestioned assumptions often prevail, unfortunately.

Aging as a systemic breakdown of the body, rather than a series of isolated events and conditions.

This 2013 diagram from NIH is a good way to jump-start contemplating the big picture:

The diagram originates from the Cell journal: The Hallmarks of Aging  

Telomere shortening is perhaps the one most talked about - but just one of several processes.  As stated in the above paper:
Each hallmark should ideally fulfill the following criteria:
(1) it should manifest during normal aging;
(2) its experimental aggravation should accelerate aging; and
(3) its experimental amelioration should retard the normal aging process and hence increase healthy lifespan. This set of ideal requisites is met to varying degrees by the proposed hallmarks

The Business Side

That was a little science background for starters - but how about financial/business considerations?

Here’s a fascinating story story about a brilliant 23 y.o. woman, Laura Deming, an MIT graduate who raised $22 million in 2017!  She formed  Longevity Fund, an early-stage venture capital company currently managing $37 millions to invest in anti-aging companies.

Fortunately, both academic researchers and companies are beginning to advance the relatively new field of anti-aging as a subject of systematic scientific pursuit, the "project Apollo" of our times.

You might have heard about the $300 M invested in Unity Biotechnology; the investors include Jeff Bezos (Amazon) and Peter Thiel (Paypal's co-founder.)

Also in recent news was the growing hub of anti-aging startups in the Boston area.  And not just Boston; the longevity companies in the San Francisco area, too, among other places.  In particular, Calico, Google's research on aging and age-related diseases, founded in 2013.  Forbes magazine, in a March 2019 article, reviews opportunities for biotech companies in the Anti-Aging market.

Explosive growth in many directions: even crowdfunding of age-related research.

Anti-aging science is well aligned with my personal research interest in Systems Biology, and in particular Interactomics: I expand on Interactomics and the future of medicine in a separate blog entry

Who's Who in the Anti-Aging Field?

(Alphabetic listing.  More entries will be progressively added as I review them.)

AgeX Therapeutics, San Francisco area, CA
Development and commercialization of novel therapeutics targeting human aging.  Its VP of New Technology Discovery is the iconic Aubrey de Grey (a name synonymous with Anti-Aging research and advocacy.)

Altos Labs, San Francisco area and San Diego, CA, as well as Cambridge, UK
See my separate entry

BioAge, San Francisco area, CA
Working on a broad pipeline of therapies to extend human healthspan and lifespan

Buck Institute for Research on Aging, Novato, CA.
The world’s first biomedical research institution devoted solely to research on aging.  In operation since 1999, it has a fairly large faculty in its own sizable campus a little north of San Francisco.  They follow many directions, and their website mentions 10 focus areas.

Calico Life Sciences,  South San Francisco, CA
Google's research on aging and age-related diseases, founded in 2013.  In an extended collaboration with the Broad Institute (MIT and Harvard.)

Celularity, Florham Park, NJ
It has demonstrated that placental-derived stem cells given to animals can extend life up to 30 percent. Celularity now aims to make this approach viable in humans. (Source: blog entry from the company's co-founder Peter Diamandis, the founder of the well-known XPRIZE Foundation.), something of an information clearinghouse on anti-aging research.

Human Longevity, San Diego, CA
Genomics and cell therapy-based diagnostic and therapeutic company focused on extending the healthy human lifespan 

InSilico Medicine, Hong Kong (also with a strong Russian collaboration.)
AI for drug discovery, biomarker development & aging research.  They sponsor the Aging Research & Drug Discovery meetings.

Juvena Therapeutics,  Palo Alto, CA
Biopharma startup developing protein-based tissue rejuvenation.

Juvenescence, San Diego, CA
Developing therapies to treat diseases of aging and increase human longevity.  Their website has a good timeline of the major breakthroughs in aging research (LEAF) New York City, NY
Life Extension Advocacy Foundation. A non-profit involved in fundraising, science journalism and running the annual conference Ending Age-Related Diseases.

MDI Biological Laboratory, Salisbury Cove, ME
Non-profit biomedical research institution with a research program in regenerative and aging biology and medicine.

OpenCures, Novato, CA
[I worked here as the CTO between June and Nov. 2020, before relocating to GSK.  During my tenure, the company started making use of the game-changing technology of graph databases, which I discuss in this entry.]
A start-up focused on using community research and individuals’ health data to discover and develop interventions in age-related disease.  Started by the co-founder of the SENS Research Foundation, Kevin Perrott.  A main focus is metabolomics - involving the measurements of a large number of biomarkers carried out by Prodrome Sciences.

Regenerative Medicine Foundation, Wellington, FL
Conferences, Patient Advocacy, Policy, Outreach and Networking

SENS Research Foundation, Mountain View, CA
A non-profit supporting
 research projects at universities and institutes, with a focus on a damage-repair paradigm for treating the diseases of aging.  It co-sponsors the large annual international conference "Undoing Aging", and was co-founded in 2009 by Aubrey de Grey.

Termis : Tissue Engineering and Regenerative Medicine International Society 

A very international nonprofit founded in 2006 

UNITY Biotechnology, South San Francisco, CA
Their initial focus is on creating "senolytic" medicines to selectively eliminate senescent cells and hopefully treat age-related diseases.
Investors include Jeff Bezos (Amazon) and Peter Thiel (Paypal's co-founder.)

Wake Forest Institute for Regenerative Medicine, Winston-Salem, North Carolina
It has been engineering laboratory-grown organs that were successfully implanted into humans.

Additional entries (142 companies as of Apr. 2021) in this spreadsheet from

Other News Sources

Longevity Technology

Events / Conferences

I've been blown away by the galloping pace of recent developments, and the rapid-fire formation of startups to explore promising directions.

As a result of Covid, some of the conference organizers finally added remote-attendance options, which makes it infinitely easier to attend them.  Hopefully, the remote options will remain in place.

Here are some conferences that I attended myself, or that I know of:

Aging Research & Drug Discovery meetings.  Sponsored by InSilico Medicine.

American Aging Association meetings.  Annual.  In its 49th year as of the next meeting.

BAAM: Bay Area Aging Meetings.  Twice/year.  Hosted by UC Berkeley, Stanford, UCSF, Buck Institute for Research on Aging, and the Gladstone Institutes.

Ending Age-Related Diseases.  Sponsored by
I attended the latest one (
Aug. 2022), and was impressed.

Metabesity.   " ‘Metabesity’ is a term coined by G Alexander Fleming MD to reference the constellation of interconnected diseases with metabolic roots. Targeting these metabolic underpinnings could be a productive approach to delaying, or even preventing, many or most of the chronic diseases of aging." (source)
I attended the latest one (Oct. 2022): another fine conference!

Undoing Aging.  Large annual international conference.

Additional entries in this spreadsheet from 

Dear conference organizers, the option of remote access to conferences OUGHT TO be given, no matter what, pandemic or not!  Conferences are meant to bring people together in different combinations, to reshuffle ideas, etc.

A conference that's only onsite is basically saying: "if you live far away, or don't have the budget or the time or the option to travel, get lost!"

The net result is cliques of people talking to each other, rather than a true global mixing!

On Social Media

My professional/scientific profile on Facebook


Facebook pages by organizations: 

Open Cures  (I worked here in 2020)

SENS Research Foundation


Facebook groups:

Ending aging: SENS, SENS Foundation, Aubrey de Grey
Informal community discussion of the work of Aubrey de Grey and SENS Research Foundation (SRF)


Review of Facebook groups:

10 Best Longevity Facebook Groups

Venture Funds lists the following Venture Funds:

Other Funding Sources


  1. Firstly, it is a mistake to think that homeostasis equals optimum. Everything about us is a compromise established largely by previous, potentially-irrelevant environmental pressures on evolution. This includes average and maximum intrinsic natural (that is, barring accidents or infections) lifespan,
    Secondly, it increasingly appears that there is indeed a natural minimum rate of biological aging, which is subject to acceleration, but cannot be halted or reversed, except by interventions that reset the balance of epigenetically-mediated genetic expression. That expression is genetically coded, and intrinsic systemic bio-aging is essentially an extension of what we commonly call 'development', which is just an early phase of biological aging. Biological aging is 'natural', and calling it that is not "...a surrender to our traditional state of ignorance and powerlessness", but rather an acknowledgement that nature has sentenced us to destructive aging and death for its own purposes. In our time, we will earn a partial or perhaps total reprieve from this sentence.


Post a Comment

Popular posts from this blog

Graph Databases (Neo4j) - a revolution in modeling the real world!

(UPDATED 11/2022) - I was "married" to Relational Databases for many years... and it was a good "relationship" full of love and productivity - but SOMETHING WAS MISSING! Let me backtrack.   In college, I got a hint of the "pre-relational database" days...  Mercifully, that was largely before my time, but  - primarily through a class - I got a taste of what the world was like before relational databases.  It's an understatement to say: YUCK! Gratitude for the power and convenience of Relational Databases and SQL - and relief at having narrowly averted life before it! - made me an instant mega-fan of that technology.  And for many years I held various jobs that, directly or indirectly, made use of MySQL and other relational databases - whether as a Database Administrator, Full-Stack Developer, Data Scientist, CTO or various other roles. But there were thorns in the otherwise happy relationship The root cause: THE REAL WORLD DOES NOT REALLY RESEMBLE THE

Life123 : Quantitative Modeling of Biological Systems

(UPDATED 8/2022) - Are we ready to embark on a next-generation detailed quantitative modeling of complex biological systems , including whole-cell simulations?  An anticipated up-jump in computing power may be imminent from Photonics computers (which I discuss here ), and GPU's are rapidly gaining power as well...  Are we in ready state to put existing - and upcoming - power to good use? This is a manifest, and a call to action What's Life123? It's about detailed quantitative modeling of biological systems in 1-D, 2-D and full 3-D, as well as a multi-faceted software platform for doing so. What's (pseudo-)1D?  For now, let's say it's like the inside of a long, thin tube - with no interactions with the tube.  Likewise, (pseudo-)2D can be thought of as a Petri dish, with no interactions with the lid or the bottom. Website : A purposeful decision to also utilize 1D and 2D But why?  Yes, it's in part about "walk before you run&quo

Discussing Neuroscience with ChatGPT

UPDATED Feb. 2023 - I'm excited by ChatGPT 's possibilities in terms of facilitating advanced learning .  For example, I got enlightening answers to questions that I had confronted when I first studied neuroscience.  The examples below are taken from a very recent session I had with ChatGPT (mid Jan. 2023.) Source: In case you're not familiar with ChatGPT, it is a very sophisticated "chatbot" - though, if you call it that way, it'll correct you!  'I am not a "chatbot", I am a language model, a sophisticated type of AI algorithm trained on vast amounts of text data to generate human-like text'. UPDATE:  this article focuses on some of the impressive abilities of ChatGPT.  For a good glimpse of its weaknesses, in the context of poor intuition about Physics, as well as Math errors, check out this great short video:  ChatGPT does Physics For a high-level explanation of how ChatGPT actually works -

D3 Visualization with Vue.js : a powerful alliance (when done right!)

[UPDATED MAY 2022]  D3.js is a very powerful visualization tool, especially for specialized/custom needs...  On the flip side, it's rather hard to use - with a steep learning curve. Even worse if one also wants interactivity ! But why is D3 so hard/clunky to use?  And what can be done about it? Spoiler alert: Vue.js (or other modern front-end framework) to the rescue - if done right... All code in the examples is available in this GitHub repository . The Root of the Problem In a nutshell, what makes D3 awkward to use is that, for historical reasons, it tries to do too much : most painfully, it uses an old way to do direct DOM manipulation (i.e. restructuring the page layout) - an operation that nowadays is superbly handled in a far more friendly way by modern front-end frameworks, such as Vue.js Document Object Model ( DOM ) is a programming interface for web documents.  In simple terms, it's the structure of the elements on a web page (text, images, etc.) Let the front-e

To Build or Not to Build One’s Own Desktop Computer?

“ VALENTINA ” [UPDATED JUNE 2021] - Whether you're a hobbyist, or someone who just needs a good desktop computer, or an IT professional who wants a wider breath of knowledge, or a gamer who needs a performant machine, you might have contemplated at some point whether to build your own desktop computer. If you're a hobbyist, I think it's a great project.  If you're an IT professional - especially a "coder" - I urge you to do it: in my opinion, a full-fledged Computer Scientist absolutely needs breath, ranging from the likes of Shannon's Information Theory and the Halting Problem - all the way down to how transistors work. And what about someone who just needs a good desktop computer?  A big maybe on that - but perhaps this blog entry will either help you, or scare you off for your own good! To build, or not to build, that is the question: Whether 'tis nobler in the mind to suffer The slings and arrows of OEM's cutting corners and limit

Brain Microarchitecture : Feedback from Higher-order areas to Lower-order areas

Some questions that arise in Machine Learning involve the prospect of using feedback from Higher-order areas (downstream) to Lower-order areas (upstream), and using Global Knowledge for Local Processing.  A desire to gain insight into those issues from Neuroscience ("how does the brain do it?") led me to some fascinating investigations into the Microcircuits of the Cerebral Cortex.  This blog entry is a broad review of the field, in the context of the original motivating questions from Machine Learning.   Starting out with a quote from the “bible of Neuroscience”: From Principles of Neural Science, 5th edn  (Online book location 1435.3 / 5867).  Emphasis and note added by me: Sensory pathways are not exclusively serial; in each functional pathway higher-order areas project back to the lower-order areas from which they receive input. In this way neurons in higher-order areas, sensitive to the global pattern of sensory input, can modulate the activity of neurons in lowe

PET/CT Combined Scanners - a 2018 Breakthrough of the Year... and a Personal Story

Image source Recently, a co-worker in her 20's was diagnosed with a brain tumor!  At times like these, the importance of medical imaging jumps to the fore! Most people have heard of CT ("CAT") scanners – at least enough to know that they don't actually involve cats – but less well-known are PET scanners (which likewise don't involve pets!), and the synergistic combination of the two. A Marriage Made in Heaven What do those scanners do?  And why are they being combined in single devices? Voted 2018 Breakthrough of the Year by a science magazine , the improved PET/CT combined scanner has been a game changer. The EXPLORER PET/CT scanner – the world’s first medical imaging system that can capture a 3D image of the entire human body simultaneously – has produced its first human images. Developed by UC Davis scientists and a multi-institutional consortium, EXPLORER can scan up to 40 times faster, or use up to 40 times less radiation dose, than

RDF Triple Stores vs. Property Graphs : How to Attach Properties to Relationships

Time for the opening shot of a series about Semantic Technology , and in particular contrasting-and-comparing the opposing (but perhaps ultimately complementary) camps of:   RDF Triple Stores , aka Triples-Based Graphs.   For example, Blazegraph or Apache Jena   (Labeled) Property Graphs .  For example, Neo4j or Blazegraph (For this article, I'll assume that you have at least a passing acquaintance with both.  Here is background info on Triplestores and Property Graphs ) It’s my opinion that modeling in terms of Subject/Predicate/Object triples (aka RDF ) might be appealing to mathematicians or philosophers for its minimalist foundation (though a lot of baroque add-on’s quickly come out of the closet!) Modeling in terms of (Labeled) Property Graphs might be appealing to computer scientists, because such graphs appear more usable and less clunky once you start actually doing something with them. Perhaps because I straddle both the Math and CS camps, I’m currently on t

A "Seismic Shift" in Longevity Science : Mainstream Acceptance + Large Funding

"You are incredibly prescient!"   I woke up to those words from a former colleague on Jan. 19, 2022: the bombshell announcement that the Chief Science Officer of pharma giant GSK, where I worked until recently, will become the CEO at the new, $3 BILLION longevity science company Altos (presumably also funded by Amazon's Jeff Bezos.) Big Pharma is at long last embracing Longevity Science. The corollary: longevity science is entering Mainstream (with capital "M") But let me backtrack... The Decade of Longevity Science When Harvard professor David Sinclair declared the 2020's to be the " decade of the paradigm shift about age reversal ", one could perhaps be dismissive of it as just an outburst of enthusiasm... But in the past couple of years, we're seeing strong evidence that his forecast is right on the mark! While I worked at GlaxoSmithKline - a giant, top-10, pharma company - I vigorously advocated forming a Longevity Science dept., and sp